ArticleJournal of bone oncology2019

Compliance and patient reported toxicity from oral adjuvant bisphosphonates in patients with early breast cancer. A cross sectional study.

C Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.